Two Sigma Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,100
Closed -$681K 4368
2020
Q4
$681K Sell
2,100
-6,900
-77% -$1.91M ﹤0.01% 2284
2020
Q3
$2.49M Buy
9,000
+7,100
+374% +$2.05M 0.01% 1170
2020
Q2
$459K Sell
1,900
-47,100
-96% -$9.46M ﹤0.01% 2059
2020
Q1
$7.11M Buy
49,000
+32,100
+190% +$5.33M 0.06% 366
2019
Q4
$2.88M Sell
16,900
-15,500
-48% -$2.87M 0.01% 1311
2019
Q3
$5.76M Buy
32,400
+20,500
+172% +$4.43M 0.02% 793
2019
Q2
$3.1M Buy
11,900
+4,900
+70% +$1.3M 0.01% 1161
2019
Q1
$2M Buy
7,000
+5,000
+250% +$1.66M 0.01% 1417
2018
Q4
$650K Sell
2,000
-1,600
-44% -$556K ﹤0.01% 1931
2018
Q3
$1.62M Buy
3,600
+600
+20% +$237K ﹤0.01% 1626
2018
Q2
$1.23M Buy
+3,000
New +$1.09M ﹤0.01% 2002
2017
Q1
Sell
-5,700
Closed -$642K 3445
2016
Q4
$642K Sell
5,700
-8,100
-59% -$938K ﹤0.01% 2337
2016
Q3
$1.77M Buy
+13,800
New +$1.65M 0.01% 1550

Other funds holding ABMD

Two Sigma Investments's ABMD Position: Q4 2022 in Review

Two Sigma Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,438 shares — an estimated $3.06M sold.

Two Sigma Investments first reported a position in ABMD in Q2 2013 and held it in 33 quarters. The position peaked at $169M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Two Sigma Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 12,438 Abiomed Inc shares in Q4 2022, an estimated $3.06M.
  • Two Sigma Investments first reported a position in Abiomed Inc in Q2 2013 and held it in 33 quarters.
  • Two Sigma Investments's Abiomed Inc position peaked at $169M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.